3'-epidaunorubicin has been researched along with idarubicin in 1 studies
| Studies (3'-epidaunorubicin) | Trials (3'-epidaunorubicin) | Recent Studies (post-2010) (3'-epidaunorubicin) | Studies (idarubicin) | Trials (idarubicin) | Recent Studies (post-2010) (idarubicin) |
|---|---|---|---|---|---|
| 5 | 0 | 0 | 1,795 | 454 | 487 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Butelli, E; Capranico, G; Zunino, F | 1 |
1 other study(ies) available for 3'-epidaunorubicin and idarubicin
| Article | Year |
|---|---|
Change of the sequence specificity of daunorubicin-stimulated topoisomerase II DNA cleavage by epimerization of the amino group of the sugar moiety.
Topics: Antibiotics, Antineoplastic; Base Sequence; Daunorubicin; DNA; DNA Topoisomerases, Type II; Doxorubicin; Idarubicin; Molecular Sequence Data; Structure-Activity Relationship | 1995 |